Activation of Cytotoxic T Lymphocyte Responses and Attenuation of Tumor Growth in vivo by Andrographis paniculata Extract and Andrographolide

REFERENCES

• Singh N.P., Yolcu E.S., Taylor D.D., Gercel-Taylor C., Metzinger D.S., Dreisbach S.K., Shirwan H. A novel approach to cancer immunotherapy: tumor cell decorated with CD80 generate effective antitumor immunity. Cancer Res. 2003; 63: 4067–4073
   PubMed Web of Science ®Google Scholar
• Tarazona R., Casado J.G., Soto R., Dela Rosa O., Peralho E., Rioja L., Pena J., Solana R. Expression of NK- associated receptors on cytotoxic T cells from melanoma patients. Cancer Immunol. Immunother. 2004; 53: 911–924
   PubMed Web of Science ®Google Scholar
• Liu Y., Ng K., Lillehei K.O. Cell-mediated immunotherapy: a new approach to the treatement of malignant glioma. Cancer Control 2003; 10: 138–146
   PubMedGoogle Scholar
• Sykulev Y., Jou M., Vturina I., Tsomides T.J., Eisen H.N. Evidence that single Peptide–MHC complex on a target cell elicit cytolytic T cell response. Immunity 1996; 4: 565–571
   PubMed Web of Science ®Google Scholar
• Qin Z., Schwartzkopft J., Pradera F., Kammertoens T., Seliger B., Pircher H., Blankenstein T.A. Critical requirement of interferon gamma mediated angiostasis for tumor rejection by CD8 + T cells. Cancer Res. 2003; 63: 4095–4100
   PubMed Web of Science ®Google Scholar
• Abe R., Peng T., Sailors J., Bucala R., Metz C.N. Regulation of the CTL response by macrophage migration inhibitory factor. J. Immunol. 2001; 166: 747–753
   PubMed Web of Science ®Google Scholar
• Sunila E.S., Kuttan G. Immunomodulatory and antitumor activity of Piper longum Linn. and Piperine. J. Ethnopharmacol. 2004; 90: 339–346
   PubMed Web of Science ®Google Scholar
• Mirandola L., Justo G.Z., Queiroz M.L.S. Modulation by Acanthospermum australe extracts of the tumor induced hematopoietic changes in mice. Immunopharmacol. Immunotoxi 2002; 24: 275–288
   PubMed Web of Science ®Google Scholar
• Tram N.T.N., Zvetkova E., Nikolova E., Katzarova E., Kostov G., Yanchev I., Baichev O. A novel in vitro and in vivo T- lymphocyte activating factor in Crinum latifolium (L.) aqueous extracts. Exp. Pathol. Parasitol. 1999; 30: 21–26
   Google Scholar
• Zhao H.Y., Fang W.Y. Antithrombotic effect of Andrographis paniculata nees in preventing myocardial infraction. Chin. Med. J. (Engl). 1991; 104: 770–775
   PubMed Web of Science ®Google Scholar
• Zhang C.Y., Tan B.K. Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat. J. Ethnopharmacol. 1997; 56: 97–101
   PubMed Web of Science ®Google Scholar
• Wang D.W., Zhao H.Y. Prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with Andrographis paniculata nees and fish oil. Chin. Med. J. (Engl). 1994; 107: 464–470
   PubMed Web of Science ®Google Scholar
• Visen P.K.S., Shukla B., Patnaik G.K. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J. Ethnopharmacol. 1993; 40: 131–136
   PubMed Web of Science ®Google Scholar
• Zhang X.F., Tan X.F. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol. Sin. 2000; 21: 1157–1164
   PubMed Web of Science ®Google Scholar
• Shen Y.C., Chen C.F., Chiou W.F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism (s) involved in its anti- inflamatory effect. Br. J. Pharmacol. 2002; 135: 399–406
   PubMed Web of Science ®Google Scholar
• Kapil A., Koul I.B., Banerjee S.K. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem. Pharmacol. 1993; 46: 182–185
   PubMed Web of Science ®Google Scholar
• Handa S.S., Sharma A. Hepatoprotective activity of Andrographolide from Andrographis paniculata against carbontetrachloride. Ind. J. Med. Res. 1990; 92: 276–283
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Aso H., Ishida N., Meida H., Schmith D. A., Pollard R.B., Suzuki F. Determination of CTL activity by winn's neutralization
   Google Scholar
• Kempf R.A., Mitchell M.S. Effect of chemotherapeutic agents on the immune response II. Cancer Invest. 1985; 3: 23–33
   PubMed Web of Science ®Google Scholar
• Santin A.D., Hermonat P.L., Ravaggi A., Bellone S., Roman J., Pecorelli S., Cannon M., Parham G.P. Effect of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48: 997–1006
   PubMed Web of Science ®Google Scholar
• Tsavaris N., Kosmas C., Vadiaka M., Kanelopoulos P., Boulamatsis D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with Taxanes. Br. J. Cancer 2002; 87: 21–27
   PubMed Web of Science ®Google Scholar
• Holladay F.P., Heitz T., Wood G.W. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocyte, but not by lymophokine-activated killer cells. J. Neurosurg. 1992; 77: 757–762
   PubMed Web of Science ®Google Scholar
• Maher J., Davies E.T. Targeting cytotoxic T lymphocyte for cancer immunotherapy. Br. J. Cancer 2004; 91: 817–821
   PubMed Web of Science ®Google Scholar
• Rooney C. M., Aguilar L.K., Huls M.H., Brenner M.K., Heslop H.E. Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T cell lines. Curr. Top. Microbiol. Immunol. 2001; 258: 221–229
   PubMed Web of Science ®Google Scholar
• Fast L.D. Recipient CD8 + cells are responsible for the rapid elimination of allogeneic donor lymphoid cells. J. Immunol. 1996; 157: 4805–4810
   PubMed Web of Science ®Google Scholar
• Romieu R., Baratin M., Kayibanda M., Lacabanne V., Ziol M., Guillet J.G., Viguier M. Passive but not active CD8 + T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse models. J. Immunol. 1998; 161: 5133–5137
   PubMed Web of Science ®Google Scholar
• Suzuki R., Suzuki S., Ebina N., Kumagai K. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cell and restoration by interferon and or interleukin 2. J. immunol. 1985; 134: 2139–2148
   PubMed Web of Science ®Google Scholar
• Marie J. E., Alistair J. R., Andrew B., Scott A.T., Coralie J.M., Ian A.R. Prime- boost immunization generates a high frequency, high-avidity CD8 + ytotoxic T lymphocyte population. IntL. Immunol. 2002; 14: 31–37
   PubMed Web of Science ®Google Scholar
• Gorer P.A. Studies in antibody response of mice to tumor inoculation. Br. J. Cancer 1950; 4: 372–379
   PubMed Web of Science ®Google Scholar
• Sanda W., Akiko U., Eiichi N. Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice. Microbiol. Immunol. 2002; 46: 513–519
   PubMed Web of Science ®Google Scholar
• Rourke A.M.O., Mescher M.F. The role of CD8 in cytotoxic T lymphocyte function. Immunol.Today 1993; 14: 183–188
   PubMedGoogle Scholar
• Taylor M.K., Cohen J.J. Cell-mediated cytotoxicity. Curr. Opin. Immunol. 1992; 4: 338–343
   PubMed Web of Science ®Google Scholar
• Berke G. Lymphocyte-triggered internal target disintegration. Immunol. Today 1991; 12: 396–399
   PubMedGoogle Scholar
• Mei-Ping C., Norman D.C. Ethanol impairs major histocompatibility complex (MHC) Class II molecule mediated but not MHC Class I molecule mediated T cell response in alcohol-consumed mice. Immunopharmacol. Immunotoxi 1999; 21: 65–87
   PubMed Web of Science ®Google Scholar
• 35. Kern, D. E.; Gillis, S.; Okada, M.; Henney, C.S. The role of interleukin-2 (IL-2) in the differentiation of cytotoxic T cells: the effect on monoclonal antibody and absorption with IL-2 dependent cell lines. J. Immunol. 1981(127), 1323–1328. assay. Immunopharmacol. Immunotoxicol. 1992(14), 841–848.
   Google Scholar
• Yuka T., Hideki O., Takashi O., Toshimasa A. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol. Invest. 2004; 33: 309–324
   PubMed Web of Science ®Google Scholar